About Mid America Division, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Mid America Division, Inc.
During the past decade, Mid America Division, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II Colon Cancer
2005-08-04
2022-12-01
Active, not recruiting
3,610
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
2006-04-07
2030-09-30
Active, not recruiting
10,273
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Sunitinib Malate or Sorafenib Tosylate in Treating Patients With Kidney Cancer That Was Removed By Surgery
2006-04-24
2021-09-01
Completed
1,943
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage IIIB or Stage IV Breast Cancer
2008-05-15
Active, not recruiting
394
Capecitabine and Lapatinib Ditosylate With or Without Cixutumumab in Treating Patients With Previously Treated HER2-Positive Stage IIIB-IV Breast Cancer
2008-07-30
2019-10-15
Completed
64
Sunitinib Malate as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy
2008-06-15
2015-05-28
Completed
210
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Mid America Division, Inc.
According to Clinical.Site data, the most researched conditions in "Mid America Division, Inc." are
"Hematological Malignancies" (1 trials) and "Myelodysplastic Syndromes" (1 trials). Many other conditions were trialed in "Mid America Division, Inc." in a lesser frequency.
Clinical Trials Intervention Types at Mid America Division, Inc.
Most popular intervention types in "Mid America Division, Inc." are "Biological" (2 trials) and "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Azacitidine" (2 trials), "Magrolimab" (2 trials) and "Placebo" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Mid America Division, Inc.
The vast majority of trials in "Mid America Division, Inc." are
2 trials for "All" genders.
Clinical Trials Status at Mid America Division, Inc.
Currently, there are NaN active trials in "Mid America Division, Inc.".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Mid America Division, Inc.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Mid America Division, Inc., 1 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".